| Literature DB >> 27895637 |
Jing Zhang1, Kai Zhou2, Beiwen Zheng2, Lina Zhao3, Ping Shen2, Jinru Ji2, Zeqing Wei2, Lanjuan Li2, Jianying Zhou4, Yonghong Xiao2.
Abstract
The aim of this work was to investigate the epidemiological and genetic characteristics of ESBL-producing Klebsiella pneumoniae (ESBL-Kp) causing community-onset infections. K. pneumoniae isolates were collected from 31 Chinese secondary hospitals between August 2010 and 2011. Genes encoding ESBL and AmpC beta-lactamases were detected by PCR. The isolates were assigned to sequence types (STs) using multi-locus sequence typing (MLST). Eleven ESBL-Kp strains were selected for whole-genome sequencing (WGS) for investigating the genetic environment and plasmids encoding ESBL genes. A total of 578 K. pneumoniae isolates were collected, and 184 (31.8%) carried ESBL genes. The prevalence of ESBL-Kp varied from different geographical areas of China (10.2-50.3%). The three most prevalent ESBL genes were blaCTX-M-14 (n = 74), blaCTX-M-15 (n = 60), and blaCTX-M-3 (n = 40). MLST assigned 127 CTX-M-14 and CTX-M-15 producers to 54 STs, and CC17 was the most prevalent population (12.6%). STs (23, 37, and 86) that were known frequently associated with hypervirulent K. pneumoniae (hvKP) account for 14.1% (18/127). Phylogenetic analysis by concatenating the seven loci of MLST revealed the existence of ESBL-producing K. quasipneumoniae (two strains) and K. varricola (one strain), which was further confirmed by WGS. This study highlights the challenge of community-onset infections caused by ESBL-Kp in China. The prevalence of STs frequently associating with hvKP should be of concern. Surveillance of ESBL-KP causing community-onset infections now appears imperative.Entities:
Keywords: CTX-M; community-onset infections; hypervirulent K. pneumoniae; resistance mechanisms; sequence type
Year: 2016 PMID: 27895637 PMCID: PMC5109008 DOI: 10.3389/fmicb.2016.01830
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Results for susceptibility tests and Minimum inhibitory concentrations (MICs) for K. pneumoniae strains (n = 587) isolated from 31 county hospitals.
| All isolates ( | ESBL-positive (phenotype) isolates ( | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Antibiotic | Resistant % | Susceptible % | MIC50(mg/L) | MIC90(mg/L) | MIC range | Resistant % | Susceptible % | MIC50(mg/L) | MIC90(mg/L) | MIC range |
| Ampicillin | 86.3 | 2.3 | 64 | >256 | 0.5–1024 | 99 | 0.5 | >256 | >256 | 1–1024 |
| Piperacillin | 38.1 | 56.7 | 8 | >256 | 0.03–1024 | 96.8 | 0 | >256 | >256 | 32–1024 |
| Ampicillin-sulbactam | 26.1 | 60.9 | 8 | 64 | 0.03–1024 | 67.9 | 10 | 32 | 128 | 0.125–1024 |
| Cefoperazone-sulbactam | 2.5 | 91.5 | 1 | 16 | 0.03–512 | 7.3 | 74.3 | 8 | 32 | 0.125–512 |
| Piperacillin-tazobactam | 1.3 | 88.2 | 4 | 32 | 0.015–1024 | 3.7 | 70 | 16 | 32 | 2–1024 |
| Cefazolin | 39.4 | 59.9 | 2 | 256 | 0.5–256 | 97.3 | 2.7 | 256 | 256 | 0.5–256 |
| Cefuroxime | 37 | 59.9 | 4 | 256 | 0.125–256 | 97.9 | 1.1 | 256 | 256 | 4–256 |
| Ceftazidime | 14.7 | 81.2 | 0.25 | 32 | 0.015–256 | 44 | 45 | 8 | 128 | 0.015–256 |
| Ceftriaxone | 31.2 | 68.1 | 0.125 | 64 | 0.03–512 | 96.8 | 1.6 | 32 | 128 | 1–512 |
| Cefepime | 11.5 | 83.3 | 0.5 | 32 | 0.03–1024 | 33.5 | 51.3 | 8 | 128 | 0.03–1024 |
| Cefoxitin | 10.2 | 86.4 | 4 | 32 | 0.25–512 | 30.4 | 65.4 | 4 | 128 | 1–512 |
| Biapenem | 0 | 100 | 0.064 | 0.125 | 0.015–1 | 0 | 100 | 0.064 | 0.125 | 0.015–1 |
| Imipenem | 0.2 | 99.8 | 0.25 | 0.25 | 0.015–16 | 0.5 | 99.5 | 0.25 | 0.25 | 0.015–16 |
| Meropenem | 0.2 | 99.8 | 0.032 | 0.125 | 0.015–16 | 0.5 | 99.5 | 0.016 | 0.125 | 0.015–16 |
| Amikacin | 7.6 | 92.4 | 2 | 8 | 0.03–512 | 20.5 | 79.5 | 2 | 128 | 0.06–512 |
| Gentamicin | 30.1 | 68.6 | 1 | 128 | 0.125–512 | 68.1 | 30.9 | 64 | 128 | 0.25–512 |
| Ciprofloxacin | 15 | 80.6 | 0.125 | 16 | 0.015–256 | 31.4 | 57.1 | 1 | 64 | 0.015–256 |
| Levofloxacin | 11.6 | 86.5 | 0.125 | 8 | 0.006–256 | 23.7 | 71.6 | 1 | 16 | .015–256 |
| Fosfomycin | 4.7 | 91.4 | 16 | 64 | 0.25–256 | 8.1 | 85.9 | 16 | 128 | 0.5–256 |
Geographical distribution of ESBL-producing K. pneumoniae isolates in seven regions of China.
| ESBL genotype | No. of isolates (prevalence, %) | |||||||
|---|---|---|---|---|---|---|---|---|
| North ( | Northwest ( | Northeast ( | East ( | South ( | Central ( | Southwest ( | Total ( | |
| CTX-M-1 group | 8 | 33 | 12 | 1 | 10 | 2 | 10 | 76 |
| CTX-M-15 | 2 | 22 | 9 | 1 | 1 | 1 | 4 | 40 |
| CTX-M-55 | 3 | 1 | 2 | 1 | 1 | 8 | ||
| CTX-M-3 | 3 | 9 | 3 | 7 | 5 | 27 | ||
| CTX-M-101 | 1 | 1 | ||||||
| CTX-M-9 group | 6 | 25 | 6 | 4 | 5 | 4 | 6 | 56 |
| CTX-M-14 | 6 | 23 | 5 | 4 | 5 | 4 | 5 | 52 |
| CTX-M-9 | 2 | 2 | ||||||
| CTX-M-27 | 1 | 1 | ||||||
| CTX-M-65 | 1 | 1 | ||||||
| SHV-type | 5 | 5 | 1 | 3 | 1 | 2 | 17 | |
| SHV-27 | 3 | 2 | 3 | 1 | 9 | |||
| SHV-2 | 2 | 1 | 3 | |||||
| SHV-12 | 2 | 1 | 1 | 4 | ||||
| SHV-41 | 1 | 1 | ||||||
| CTX-M-1+9 groups | 15 | 3 | 2 | 1 | 21 | |||
| CTX-M-14 +CTX-M-3 | 6 | 1 | 2 | 9 | ||||
| CTX-M-14+ CTX-M-15 | 6 | 2 | 8 | |||||
| CTX-M-15+ CTX-M-24 | 1 | 1 | ||||||
| CTX-M-15+ CTX-M-9 | 3 | 3 | ||||||
| CTX-M+SHV | 3 | 9 | 1 | 1 | 14 | |||
| CTX-M-3+SHV-2 | 2 | 1 | 3 | |||||
| CTX-M-3+SHV-12 | 1 | 1 | ||||||
| CTX-M-15+SHV-12 | 1 | 1 | ||||||
| CTX-M-14+SHV-2 | 1 | 1 | ||||||
| CTX-M-14+SHV-27 | 1 | 1 | ||||||
| CTX-M-15+SHV-27 | 1 | 1 | ||||||
| CTX-M-14+CTX-M-15+ SHV-27 | 2 | 2 | ||||||
| CTX-M-14+CTX-M-15+ SHV-38 | 1 | 1 | ||||||
| CTX-M-15+CTX-M-9+ SHV-27 | 3 | 3 | ||||||
| Total | 22 (31.0%) | 86 (50.3%) | 23 (31.9%) | 5 (10.2%) | 20 (38.5%) | 9 (45.0%) | 19 (13.3%) | 184 (31.8%) |